The solute carrier SLC35F2 enables YM155-mediated DNA damage toxicity

Winter, Georg E, Radic, Branka, Mayor-Ruiz, Cristina, Blomen, Vincent A, Trefzer, Claudia, Kandasamy, Richard K, Huber, Kilian V M, Gridling, Manuela, Chen, Doris, Klampfl, Thorsten, Kralovics, Robert, Kubicek, Stefan, Fernandez-Capetillo, Oscar, Brummelkamp, Thijn R, Superti-Furga, Giulio·2014·Nature Chemical Biology
DOI 10.1038/nchembio.1590

Cited by (177)

Items 101–177 of 177

  1. Hitchhiking into the cell
    Douglas Bruce Kell · 2020 · Nature Chemical Biology
  2. Multi‐omics integration identifies a selective vulnerability of colorectal cancer subtypes to YM155
    Tianzuo Zhan, Verena Faehling, Benedikt Rauscher, Johannes Betge, Matthias P. Ebert, Michael Boutros · 2020 · International Journal of Cancer
  3. Control of metabolite efflux in microbial cell factories: current advances and future prospects
    Douglas Bruce Kell · 2018 · OSF Preprints (OSF Preprints)
  4. Mammalian haploid stem cells: establishment, engineering and applications
    Wenteng He, Jiayu Chen, Shaorong Gao · 2019 · Cellular and Molecular Life Sciences
  5. Testing of the Survivin Suppressant YM155 in a Large Panel of Drug-Resistant Neuroblastoma Cell Lines
    Martin Michaelis, Yvonne Voges, Florian Rothweiler, Fabian Weipert, Amara Zia-Ahmad, Jaroslav Činátl, Andreas von Deimling, Frank Westermann, Franz Rödel, Mark N. Wass et al. · 2020 · Cancers
  6. Effect of Sepatronium Bromide (YM-155) on DNA Double-Strand Breaks Repair in Cancer Cells
    Dušana Majera, Martin Mistrík · 2020 · International Journal of Molecular Sciences
  7. YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site
    Ryan P. Mackay, Paul Weinberger, John Alton Copland, Elahe Mahdavian, Qinqin Xu · 2022 · Molecular Cancer Therapeutics
  8. Intelligent host engineering for metabolic flux optimisation in biotechnology
    Lachlan Jake Munro, Douglas Bruce Kell · 2021 · Biochemical Journal
  9. Knockdown of SLC35F2 Inhibits the Proliferation and Metastasis of Bladder Cancer Cells
    Mei Chen, Xin Gao, Denggao Huang, Shunlan Wang, Linlin Zheng, Yinyi Chen, Xiaohong Wen, Yuanhui Gao, Hui Cao, Shufang Zhang · 2019 · OncoTargets and Therapy
  10. Solute Carrier Family 35 (SLC35)—An Overview and Recent Progress
    Shin Kamiyama, Hideyuki Sone · 2024 · Biologics
  11. Identification and Engineering of Transporters for Efficient Melatonin Production in Escherichia coli
    Lei Yang, Sailesh Malla, Emre Özdemir, Se Hyeuk Kim, Rebecca M. Lennen, Hanne Bjerre Christensen, Ulla Christensen, Lachlan Jake Munro, Markus J. Herrgård, Douglas Bruce Kell et al. · 2022 · Frontiers in Microbiology
  12. The oncogene SLC35F2 is a high-specificity transporter for the micronutrients queuine and queuosine
    Burtnyak, Lyubomyr, Yuan, Yifeng, Stojek, Erwina, Pan, Xiaobei, Gunaratne, Lankani, Silveira d’Almeida, Gabriel, Fergus, Claire, Martinelli, Maria, J. Reed, Colbie, Fernandez, Jessie et al. · 2025 · Proceedings of the National Academy of Sciences
  13. Synergistic cytotoxicity of decitabine and YM155 in leukemia cells through upregulation of SLC35F2 and suppression of MCL1 and survivin expression
    Jing‐Ting Chiou, Long‐Sen Chang · 2023 · APOPTOSIS
  14. Genotoxicity and immunotoxic effects of 1,2-dichloroethane in Wistar rats
    Iqbal M. Lone, Nazia Nazam, Aashiq Hussain, Shashank Kumar Singh, Abid Hamid Dar, Rauf Ahmad Najar, Mohammed Hussein Al-Qahtani, Waseem Ahmad · 2016 · Journal of Environmental Science and Health Part C
  15. Generation of a Small Library of Natural Products Designed to Cover Chemical Space Inexpensively
    Steve O’Hagan, Douglas Bruce Kell · 2019
  16. YM155 sensitizes HeLa cells to TRAIL‑mediated apoptosis via cFLIP and survivin downregulation
    Arun Chandrasekaran, Naresh Poondla, Na Re Ko, Seung Oh, Suresh Ramakrishna · 2020 · Oncology Letters
  17. Survivin suppression heightens BZML-induced mitotic catastrophe to overcome multidrug resistance by removing therapy-induced senescent A549/Taxol cells
    Zhaoshi Bai, Yiran Zhou, Xinyue Ye, Yupeng Li, Yaling Peng, Qi Guan, Weige Zhang, Lingman Ma · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  18. Using Single-Cell RNA Sequencing and MicroRNA Targeting Data to Improve Colorectal Cancer Survival Prediction
    Andrew Willems, Nicholas L. Panchy, Tian Hong · 2023 · Cells
  19. E3 ubiquitin ligase APC/CCdh1 regulates SLC35F2 protein turnover and inhibits cancer progression in HeLa cells
    Jencia Carminha Colaco, Arun Pandian Chandrasekaran, Janardhan Keshav Karapurkar, D A Ayush Gowda, Girish Birappa, Sripriya Rajkumar, Bharathi Suresh, Na Re Ko, Seok‐Ho Hong, Seung Jun Oh et al. · 2023 · Biochimica et Biophysica Acta (BBA) - General Subjects
  20. Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l -Type Amino Acid Transporter 1-Utilizing Prodrugs
    Johanna Huttunen, Thales Kronenberger, Ahmed B. Montaser, Adéla Králová, Tetsuya Terasaki, Antti Poso, Kristiina M. Huttunen · 2023 · Molecular Pharmaceutics
  21. YM155-Adapted Cancer Cell Lines Reveal Drug-Induced Heterogeneity and Enable the Identification of Biomarker Candidates for the Acquired Resistance Setting
    Martin Michaelis, Mark N. Wass, Ian G. Reddin, Yvonne Voges, Florian Rothweiler, Stephanie Hehlgans, Jaroslav Činátl, Marco Mernberger, Andrea Nist, Thorsten Stiewe et al. · 2020 · Cancers
  22. 5‐Arylidene‐2‐(4‐hydroxyphenyl)aminothiazol‐4(5H)‐ones with selective inhibitory activity against some leukemia cell lines
    Ivanna Subtel’na, Anna Kryshchyshyn‐Dylevych, Ruochen Jia, Maryan I. Lelyukh, Anna Ringler, Stefan Kubicek, Oleh Zagrijtschuk, Róbert Královics, Roman Lesyk · 2020 · Archiv der Pharmazie
  23. Why most transporter mutations that cause antibiotic resistance are to efflux pumps rather than to import transporters
    Pedro Mendes, Enrico Girardi, Giulio Superti‐Furga, Douglas Bruce Kell · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  24. The mechanistic effects of the dioxonaphthoimidazolium analog YM155 in renal cell carcinoma cell cycling and apoptosis
    Mei Yi Sim, Mei‐Lin Go, John Shyi Peng Yuen · 2018 · Life Sciences
  25. Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells
    Hua Min Shen, Cliona M. McHale, Syed I. Haider, Cham Jung, Susie Zhang, Martyn T. Smith, Luoping Zhang · 2016 · Toxicological Sciences
  26. Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells
    Hua Min Shen, Cliona M. McHale, Syed I. Haider, Cham Jung, Susie Zhang, Martyn T. Smith, Luoping Zhang · 2016 · Toxicological Sciences
  27. YM155 induces apoptosis in p53-deficient T-acute lymphoblastic leukemia cells independent of survivin inhibition
    Leilane Sales, Graziella Ribeiro de Sousa, Guilherme Álvaro Ferreira‐Silva, Angel Maurício Castro‐Gamero, Marisa Ionta, Jaqueline Carvalho de Oliveira · 2016 · Anti-Cancer Drugs
  28. Vector Integration Sites Identification for Gene-Trap Screening in Mammalian Haploid Cells
    Jian Yu, Constance Ciaudo · 2017 · Scientific Reports
  29. Predicting substrates for orphan solute carrier proteins using multi-omics datasets
    Zhang, Y., Newstead, S., Sarkies, P. · 2025 · BMC Genomics
  30. Functional-genetic approaches to understanding drug response and resistance
    Matthias Hinterndorfer, Johannes A. Zuber · 2019 · Current Opinion in Genetics & Development
  31. Overexpression of SLC35F2 is a potential prognostic biomarker for lung adenocarcinoma
    Qingzhu Zheng, Mingjie Li, Ying‐Kun Qiu, Jiahao Yang, Yingping Cao · 2023 · Heliyon
  32. ONC212 enhances YM155 cytotoxicity by triggering SLC35F2 expression and NOXA-dependent MCL1 degradation in acute myeloid leukemia cells
    Jing‐Ting Chiou, Long‐Sen Chang · 2024 · Biochemical Pharmacology
  33. Extended transcriptome analysis reveals genome-wide lncRNA-mediated epigenetic dysregulation in colorectal cancer
    Sha He, Juanzhi Chen, Huan Gao, Guixian Yang, Feixiang Zhang, Yan-qing Ding, Hao Zhu · 2020 · Computational and Structural Biotechnology Journal
  34. The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis
    DARIIMAA GANBAT, Bat‐Erdene Jugder, Lkhamaa Ganbat, Miki Tomoeda, Erdenetsogt Dungubat, Yoshihisa Takahashi, Ichiro Mori, Takayuki Shiomi, Yasuhiko Tomita · 2021 · Current Cancer Drug Targets
  35. Engineering and characterization of small-molecule transporters for cell factories
    Yuesheng Zhang, Douglas Bruce Kell, Irina Borodina · 2025 · Trends in biotechnology
  36. Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [11C]YM155
    Keisuke Mitsuoka, Aya Kita, Yoshihiro Murakami, Kenna Shirasuna, Akihiro Noda, Kentaro Yamanaka, Naoki Kaneko, Sosuke Miyoshi · 2018 · Nuclear Medicine and Biology
  37. Quantitative and multiplexed chemical-genetic phenotyping in mammalian cells with QMAP-Seq
    Sonia Brockway, Geng Wang, Jasen M. Jackson, David R. Amici, Seesha R. Takagishi, Matthew R. Clutter, Elizabeth T. Bartom, Marc L. Mendillo · 2020 · Nature Communications
  38. Use of the Naphthoquinone YM155 (Sepantronium Bromide) in the Treatment of Cancer: A Systematic Review and Meta-Synthesis
    DARIIMAA GANBAT, Bat‐Erdene Jugder, Lkhamaa Ganbat, Miki Tomoeda, Erdenetsogt Dungubat, Ambaga Miegombo, Gantsetseg Garmaa, Yoshihisa Takahashi, Ryuji Fukuzawa, Ichiro Mori et al. · 2022 · ONCOLOGIE
  39. Helping Induced hPSCs Clean Up Their Act.
    Ho-Chang Jeong, Hyuk-Jin Cha · 2017 · Cell Chemical Biology
  40. Consensus rank orderings of molecular fingerprints illustrate the ‘most genuine’ similarities between marketed drugs and small endogenous human metabolites, but highlight exogenous natural products as the most important ‘natural’ drug transporter substrates
    Steve O’Hagan, Douglas Bruce Kell · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  41. Memorization Bias Impacts Modeling of Alternative Conformational States of Symmetric Solute Carrier Membrane Proteins with Methods from Deep Learning
    G.V.T. Swapna, Namita Dube, Monica J. Roth, Gaetano Thomas Montelione · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  42. βTrCP1 promotes SLC35F2 protein ubiquitination and inhibits cancer progression in HeLa cells
    Jencia Carminha Colaco, Arun Pandian Chandrasekaran, Janardhan Keshav Karapurkar, Girish Birappa, Sripriya Rajkumar, D A Ayush Gowda, Bharathi Suresh, Junwon Lee, Vijai Singh, Seok‐Ho Hong et al. · 2023 · Biochemical and Biophysical Research Communications
  43. Evidence for the Role of the Mitochondrial ABC Transporter MDL1 in the Uptake of Clozapine and Related Molecules into the Yeast Saccharomyces cerevisiae
    Chrispian William Theron, Jesus Enrique Salcedo-Sora, Justine M. Grixti, Iben Møller‐Hansen, Irina Borodina, Douglas Bruce Kell · 2024 · Pharmaceuticals
  44. Response to ‘The Need for Speed’, by Matsson et al .
    Pedro Mendes, Stephen G. Oliver, Douglas Bruce Kell · 2016 · Trends in Pharmacological Sciences
  45. The Need for Speed–Kinetic Limits of Drug Transporters
    Pär Matsson, Patrik Lundquist, Per Artursson · 2016 · Trends in Pharmacological Sciences
  46. Metabolic Control Analysis
    Peter Mulquiney, Philip W. Kuchel · 2003 · CRC Press eBooks
  47. Insights into Transporter Classifications: an Outline of Transporters as Drug Targets
    Michael Viereck, Anna Gaulton, Daniela Digles · 2017 · Methods and principles in medicinal chemistry
  48. A generative deep neural network for pan-digestive tract cancer survival analysis
    Lekai Xu, Tianjun Lan, Yiqian Huang, Liansheng Wang, Junqi Lin, Xinpeng Song, Hui Tang, Haotian Cao, Hua Chai · 2025 · BioData Mining
  49. The tales of two organic cation transporters, OCT-1 and OCT-2, in C. elegans
    Dindial Ramotar · 2017 · ADMET & DMPK
  50. Novel 'Housekeeping' Genes and an Unusually Heterogeneous Distribution of Transporter Expression Profiles in Human Tissues and Cell Lines, Assessed Using the Gini Coefficient
    Steve O’Hagan, Marina Wright Muelas, Philip J. Day, Emma K. Lundberg, Douglas Bruce Kell · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  51. Scarless Enriched selection of Genome edited Human Pluripotent Stem Cells Using Induced Drug Resistance
    Keun-Tae Kim, Ju-Chan Park, Haeseung Lee, Hyeon-Ki Jang, Yangyang Jin, Wankyu Kim, Jeongmi Lee, H. Kim, Sangsu Bae, Hyuk-Jin Cha · 2019 · bioRxiv
  52. EXPERIMENTAL APPROACHES FOR STUDYING DRUG TRANSPORTERS
    Yusuke Masuo, Azusa Futatsugi, Yukio Kato · 2022
  53. 2016 EMBO Chemical Biology Conference
    Satpal Virdee · 2016 · ChemBioChem
  54. DNA analysis of cattle parasitic protozoan Tritrichomonas foetus after photodynamic therapy
    A. Margraf-Ferreira, Isabel Chaves Silva Carvalho, Salomão Mafalda Machado, Cristina Pacheco Soares, Carolina Weigert Galvão, Rafael Mazer Etto, Newton Soares da Silva · 2017 · Photodiagnosis and Photodynamic Therapy
  55. Differential metabolic profiles mediated SLC1A2 confer resistance in glioblastoma therapies : stratification goals and implementation
    Lynnette Koh · 2019
  56. Peer Review #3 of "The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities (v0.2)"
    2015 · PeerJ
  57. Peer Review #3 of "The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities (v0.1)"
    2015 · PeerJ
  58. Peer Review #4 of "The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities (v0.2)"
    2015 · PeerJ
  59. Increased expression of SLC35F2 in non-small cell lung cancer predicts poor prognosis
    Wei Peng, Zhenjie Huang, Guangnan Liu · 2020
  60. Peer Review #2 of "The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities (v0.1)"
    2015 · PeerJ
  61. Peer Review #1 of "The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities (v0.1)"
    2015 · PeerJ
  62. Metabolic Control Analysis
    2003 · CRC Press eBooks
  63. Faculty Opinions recommendation of Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import.
    Bruno Stieger · 2020 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  64. Peer Review #2 of "The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities (v0.2)"
    2015 · PeerJ
  65. Peer Review #5 of "The apparent permeabilities of Caco-2 cells to marketed drugs: magnitude, and independence from both biophysical properties and endogenite similarities (v0.2)"
    2015 · PeerJ
  66. Data from YM155 Induces DNA Damage and Cell Death in Anaplastic Thyroid Cancer Cells by Inhibiting DNA Topoisomerase IIα at the ATP-Binding Site
    Ryan P. Mackay, Paul Weinberger, John Alton Copland, Elahe Mahdavian, Qinqin Xu · 2023
  67. Integrative analyses of bulk, single-cell and spatial transcriptomics identified diabetes mellitus-related signature as a prognostic factor in pancreatic adenocarcinoma
    Le Min Tang, Tongji Xie, Guangyu Fan, Haohua Zhu, Jiarui Yao, Yuankai Shi · 2023 · Research Square
  68. A kinetic study of multi-substrate uniporters
    Ana S. De Pereda, Jihyun Park, Lily S. Cheung · 2025 · Journal of Theoretical Biology
  69. Diabetes-associated metabolic-immune signature stratifies survival and immunotherapy response in pancreatic adenocarcinoma through multi-omics integration
    Le Min Tang, Mengwei Yang, Tongji Xie, Guangyu Fan, Haohua Zhu, Jiari Yao, Xiaohong Han, Yuankai Shi · 2025 · Intelligent Pharmacy
  70. Fluorescent dyes as functional probes for studying drug-transporting solute carriers
    Olivier Fardel, A Moreau, Hélène Le Mentec, Claire Denizot, David Malnoë, Yannick Parmentier · 2026 · Xenobiotica
  71. Solute carrier transporters in tumor metabolism and tumor immunity
    Miaobo Chen, J F Xu, Heling Ma, Jinlong Qin, Jiajing Cheng, Jia Lv · 2026 · Chemico-Biological Interactions
  72. Exploiting HSD17B11-dependent dialkynylcarbinols cytotoxicity for facile CRISPR/Cas9-based gene inactivation
    Bastien Dumais, Madeleine Bossaert, Patrick Seigneur, Alexandrine Rozié, Sophie Gasmi, Luce Fontanié--Roger, Maëlle Caroff, Valérie Maraval, Vania Bernardes‐Génisson, Dennis Gómez et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  73. Over-expression of the solute carrier gene SLC23A1 as a novel mechanism contributing to imidacloprid resistance in Nilaparvata lugens
    Fan Zhang, Zhi-Tao Yu, Yan‐Chao Zhang, Yu-Qiu Xie, Lixiang Wang, Cong‐Fen Gao · 2026 · Insect Biochemistry and Molecular Biology
  74. SLC35F2 in Cancer Development and Progression
    Si Shen, Zhonghao Tang, Chen Guo, 李四喜, Anjie Chen, Chenwei Gu, Yuanyuan Mi · 2026 · Journal of Cellular Physiology
  75. BindingDB Entry 50020587: Small Molecule Inhibitors Targeting the "Undruggable" Survivin: The Past, Present, and Future from a Medicinal Chemist's Perspective.
    BindingDB · 2024 · UC San Diego
  76. BindingDB Entry 50007948: The Druggability of Solute Carriers.
    BindingDB · 2021 · UC San Diego
  77. BindingDB Entry 50000311: Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts.
    BindingDB · 2019 · UC San Diego